首页> 美国卫生研究院文献>Human Gene Therapy >Large-Scale Production of High-Quality Helper-Dependent Adenoviral Vectors Using Adherent Cells in Cell Factories
【2h】

Large-Scale Production of High-Quality Helper-Dependent Adenoviral Vectors Using Adherent Cells in Cell Factories

机译:使用细胞工厂中的贴壁细胞大规模生产高质量的依赖助手的腺病毒载体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The most efficient and widely used system for generating helper-dependent adenoviral vectors (HDAds) is the Cre/loxP system developed by Graham and co-workers (Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, M.A., and Graham, F.L. []. Proc. Natl. Acad. Sci. U. S. A. 93, 13565–13570). Alternative systems have been developed for HDAd production, but all are limited by the technical complexity of a three-component vector production system for reproducibly generating large quantities of adenovirus with high infectivity and low helper virus (HV) contamination. Recently, these problems were addressed by Ng and co-workers (Palmer, D., and Ng, P. []. Mol Ther. 8, 846–852), who developed an improved system that combines the use of a suspension-adapted producer cell line expressing high levels of Cre recombinase, a HV resistant to mutation, and a refined purification protocol. With this system, >1 × 1013 highly infectious vector particles are easily produced without vector genome rearrangements and having very low HV contamination levels. However, the Ng system incorporates a spinner flask culture system that involves considerable time, effort, and tissue culture medium to produce HDAds. We have an alternative system to obtain comparable quantities with equivalent quality to the spinner flask approach but requiring reduced labor and lower volumes of medium. This method utilizes a 10-chamber cell factory with adherent cells to produce high infectivity of HDAds with minimal HV contamination while improving yield and reducing technical complexity, effort, and medium requirements. This system is easily translatable to the production of clinical-grade HDAds for human trials.
机译:由Graham及其同事(Parks,RJ,Chen,L.,Anton,M.,Sankar,U.,Parker等)开发的Cre / loxP系统是产生辅助依赖型腺病毒载体(HDAds)的最有效和广泛使用的系统。马萨诸塞州的鲁德尼基(Rudnicki)和佛罗里达州的格雷厄姆(Graham)(美国),美国国家科学院院刊93,13565–13570。已经开发了用于HDAd生产的替代系统,但是所有这些都受到三组分载体生产系统技术复杂性的限制,该系统可重复生成大量具有高传染性和低辅助病毒(HV)污染的腺病毒。最近,Ng及其同事(Palmer,D.和Ng,P. [Mol Ther。8,846-852])解决了这些问题,他们开发了一种改进的系统,该系统结合了适应悬架的使用生产细胞表达高水平的Cre重组酶,对突变具有抗性的HV和精细的纯化方案。通过该系统,可以容易地产生> 1××10 13 高传染性载体颗粒,而无需进行载体基因组重排,并且具有极低的HV污染水平。但是,Ng系统结合了一个旋转瓶培养系统,该系统需要大量的时间,精力和组织培养基才能生产HDAd。我们有一个替代系统,可以以与转瓶法相当的质量获得可比较的数量,但需要的工作量减少,介质的体积也减少了。该方法利用具有粘附细胞的10室细胞工厂来产生高感染力的HDAd,同时将HV污染降至最低,同时提高产量并降低技术复杂性,工作量和培养基要求。该系统可轻松转换为用于人体试验的临床级HDAds生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号